Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hořovice
Clinical trial register · Czechia

Clinical Trials in Hořovice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1522 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
1522
Studies in scope
all four open statuses
785
Recruiting now
open to new participants
303
Lead sponsors
across recruiting studies
Top sites
Prague 1087 Brno 612 Hradec Králové 324 Olomouc 315 Ostrava 285

Trials with a site in Hořovice

24 of 1522 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
CatalYm GmbH
Phase 2/3
518
Hořovice, Hradec Králové, Olomouc, Prague
2026-04-16
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Hořovice, Vítkovice
2025-11-30
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Hořovice, Liberec, Olomouc, Prague, Zlín
2025-11-03
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Brno, Hořovice, Hradec Králové, Nový Jičín, Olomouc, Prague
2025-08-26
Recruiting
Celcuity Inc
Phase 3
1,180
Brno, Hořovice, Hradec Králové, Olomouc, Prague
2025-07-24
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
MedSIR
Phase 3
300
Brno, Hořovice, Olomouc, Prague, Zlín
2024-12-05
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Brno, Hořovice, Prague
2024-09-27
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
České Budějovice, Hořovice, Hradec Králové, Nový Jičín, Olomouc, Prague, Tábor, Vodňany
2024-07-31
Active, closed
Takeda
Phase 2
213
Hořovice, Brno, Hradec Králové, Ostrava, Ostrava-Poruba, Pardubice, Prague, Ústí nad Labem
2024-03-29
Recruiting
Takeda
Phase 2
268
Hořovice, Brno, České Budějovice, Hradec Králové, Ostrava, Ostrava-Poruba, Pardubice, Prague
2024-03-05
Recruiting
AstraZeneca
Phase 3
4,300
Hořovice, Pardubice, Prague, Pragues, Příbram
2023-03-31
Active, closed
Eli Lilly and Company
Phase 3
8,000
Brno, Hořovice, Hradec Králové, Ostrava, Pardubice, Prague
2022-10-04
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
Revolution Medicines, Inc.
Phase 1
222
Hořovice, Hradec Králové, Olomouc
2022-09-19
Active, closed
Eli Lilly and Company
Phase 3
925
Hořovice, Brno, Prague, Příbram, Hradec Králové
2022-04-14
Active, closed
AstraZeneca
Phase 3
1,035
Hořovice, Hradec Králové, Pardubice, Prague
2022-03-25
Active, closed
Eli Lilly and Company
Phase 3
874
Hořovice, Prague, Příbram
2021-10-04
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Hořovice, Olomouc, Prague, Praha 8 - Liben
2021-02-23
Active, closed
AstraZeneca
Phase 3
1,371
Hořovice, Hradec Králové, Nový Jičín, Prague
2021-01-28
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Hořovice, Olomouc, Ostrava, Prague, Praha 8 - Liben
2020-12-02
Active, closed
AstraZeneca
Phase 3
1,012
Brno, Hořovice, Hradec Králové, Prague
2020-07-13
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
České Budějovice, Hořovice, Hradec Králové, Prague
2018-04-13
Active, closed
Eli Lilly and Company
Phase 3
5,637
Hořovice, Brno, Ostrava, Pardubice, Prague, Pilsen
2017-07-12
Active, closed
Tesaro, Inc.
Phase 1
729
Hořovice, Zlín
2016-03-07
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-czechia/city/ho-ovice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,522 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Hořovice.

How many clinical trials are recruiting in Hořovice?

10 of the 24 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hořovice), 24 studies
PhaseStudiesRecruitingShare
Phase 317770.8%
Phase 2/33212.5%
Phase 1208.3%
Phase 2218.3%

Most active sponsors

Lead sponsors with the most studies (Hořovice)
Lead sponsorStudiesRecruiting
AstraZeneca52
Eli Lilly and Company40
Mirati Therapeutics Inc.21
Takeda21
Astellas Pharma Global Development, Inc.10
CatalYm GmbH11
Celcuity Inc11
Janssen Research & Development, LLC10
MedSIR11
Olema Pharmaceuticals, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.